Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
NUVL | Nuvalent, Inc. | Director | $222 M | -$64 M | -22.4% | Jun 12, 2024 |
DVAX | DYNAVAX TECHNOLOGIES CORP | Director | $13.9 M | -$21.6 M | -60.9% | Aug 8, 2023 |
MRSN | Mersana Therapeutics, Inc. | Director | Jun 11, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|